Evidence map›Paper›PMID 40362523›Full record

ReviewInternational journal of molecular sciences2025

Decoding Macrophage Dynamics: A Pathway to Understanding and Treating Inflammatory Skin Diseases.

Shengliang Gu, Lei Xu, Bin Huang, Kai Xiong, Xuesong Yang, Jianzhou Ye

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Microorganisms · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shengliang GuThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
Lei XuThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
Bin HuangThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.ORCID 0000-0002-5486-7924
Kai XiongThe First School of Clinical Medicine, Guizhou University of Chinese Medicine, Guiyang 550025, China.
Xuesong YangThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
Jianzhou YeThe First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.

Funding

the National Natural Science Foundation of China No. 82260940the Scientific Research Foundation of Yunnan Provincial Education Department 2024Y404
6 · The paper itself

Abstract

Psoriasis and atopic dermatitis (AD) are both chronic inflammatory skin diseases. Their pathogenesis remains incompletely understood. The polarization states of macrophages, as a crucial part of the innate immune system, are influenced by various factors such as cytokines, inflammatory mediators, and epigenetics. Research has demonstrated that macrophages play a "double-edged sword" role in the pathological process of inflammatory skin diseases: they both drive inflammation progression and participate in tissue repair. This article summarizes the roles of macrophages in the inflammatory development and tissue homeostasis of psoriasis and atopic dermatitis. It explores the impact of different factors on macrophages and inflammatory skin diseases. In conclusion, understanding the classification and plasticity of macrophages is crucial for a deeper understanding of the pathogenesis of psoriasis and AD and the development of personalized treatments.

Indexed as

Dermatitis, AtopicMacrophagesPsoriasisSkin DiseasesAnimalsCytokinesHumansInflammationCytokinesatopic dermatitisepigeneticsinflammatory dermatosismacrophage polarizationpsoriasis

Identifiers

PMID40362523
PMCPMC12071885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.